The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.
about
Noncoding RNAs in endocrine malignancyPheochromocytoma and paraganglioma: diagnosis, genetics, management, and treatmentIncreased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patientsMulti-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas.Role of miR-101 in pheochromocytoma patients with SDHD mutation.Molecular and therapeutic advances in the diagnosis and management of malignant pheochromocytomas and paragangliomasCPEB1, a histone-modified hypomethylated gene, is regulated by miR-101 and involved in cell senescence in gliomaLncRNAs expression profiling in normal ovary, benign ovarian cyst and malignant epithelial ovarian cancer.MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy.Circulating miRNAs as biomarkers for endocrine disorders.Rethinking pheochromocytomas and paragangliomas from a genomic perspective.The role of miRNAs in the pheochromocytomas.Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.Loss of has-miR-337-3p expression is associated with lymph node metastasis of human gastric cancer.Retinoic acid induced 16 enhances tumorigenesis and serves as a novel tumor marker for hepatocellular carcinoma.MiR-483-5p promotes IGF-II transcription and is associated with poor prognosis of hepatocellular carcinoma.Identification of miRNAs as potential new biomarkers for nervous system cancer.Role of miR-483 in digestive tract cancers: from basic research to clinical value.
P2860
Q33577889-C97B9DC3-F76D-411C-BA18-675CF0211E1AQ34410500-1C481D3C-0466-4BFF-A1ED-2DDE0CDF999BQ34654554-D6224F39-BD19-4C6D-BF80-B74D2281240CQ35160825-F6624795-3EE3-47A5-B2D0-65D928951849Q35405433-67A6EF3E-3D63-4EF5-9B6A-E92BDF9FC41AQ36804496-E4FC2015-3D62-46B1-83B5-B4AB0F1FD699Q36985123-DEC1403F-96D1-4378-BDCA-B793BD57DA13Q37492937-9896A9EF-3B03-49D3-832F-214F9B7FC5D1Q38258284-DAECFAF3-719E-48D9-9C61-BEE831409127Q38503895-5A916BBE-352C-4BCB-897B-648957910200Q38509463-FB32F879-7BF8-4AAB-A83E-C07C64EF17E3Q38606234-88E1FDC9-176C-4B8A-A6F9-51789348E9B5Q38801063-648FE16C-5E7C-416E-BE63-C6DDE9D0D2C6Q39034592-49F0119B-788C-4FDB-97E6-D8EE71E63ECCQ45881792-B99A3834-82A1-41D3-976F-807FDEFCDB98Q47113848-DC3DF4C1-EE19-4155-8373-5E97C85AE0ABQ48595509-C948A04F-A509-4935-B3CF-C9275A050B1BQ49313057-C981869C-57AA-4AD7-A52A-B91A00FC13EA
P2860
The microRNA expression changes associated with malignancy and SDHB mutation in pheochromocytoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The microRNA expression change ...... mutation in pheochromocytoma.
@ast
The microRNA expression change ...... mutation in pheochromocytoma.
@en
type
label
The microRNA expression change ...... mutation in pheochromocytoma.
@ast
The microRNA expression change ...... mutation in pheochromocytoma.
@en
prefLabel
The microRNA expression change ...... mutation in pheochromocytoma.
@ast
The microRNA expression change ...... mutation in pheochromocytoma.
@en
P2093
P2860
P356
P1476
The microRNA expression change ...... mutation in pheochromocytoma.
@en
P2093
A K Holloway
A Weisbrod
E Patterson
P2860
P304
P356
10.1530/ERC-11-0308
P577
2012-04-10T00:00:00Z